Response to systemic therapy in locally advanced and metastatic renal cell carcinoma: can it be predicted?

: Renal cell carcinoma is no longer considered a monolithic disease, but a group of different entities exhibiting unique molecular alterations requiring a tailored systemic approach. One of the rem...